SEC Form 4 · accession 0001209191-17-009691
NUVASIVE INC · NUVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edmund J Roschak
Officer — CEO, NuVasive Spec. Orthopedic
Period of report
Feb 8, 2017
Accepted (ET)
Feb 10, 2017 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001142596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRSUsF1,F2 | $0.00 | Feb 8, 2017 | A | 11,143 | A | — | — | Common Stock | 11,143 | 11,143 | D |
Explanation of responses
- F1Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting.
- F2This PRSU award was granted to the Reporting Person on April 1, 2016. On February 8, 2017, the Compensation Committee of the Issuer's Board of Directors certified that the PRSU award's performance condition had been satisfied. In accordance with the terms of the PRSU award, the award will vest in full on April 1, 2019. As the PRSU award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant.